Welcome to Juvaris BioTherapeutics
Juvaris BioTherapeutics, located in Burlingame, California,
is developing therapeutic vaccines for cancer and infectious
diseases using its novel technology platform of cationic lipids
and non-coding DNA complexes. These complexes are capable of
up-regulating the immune response, in particular cell-mediated
immunity, at least 20-fold greater than existing technologies.
The company has completed pre-clinical studies in many species
including rodents and dogs, established manufacturing processes,
and secured contract suppliers; positioning the company to initiate
toxicology studies leading to clinical trials. |
